We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mutation in Connexin 43 Causes Developmental Disorder

By Biotechdaily staff writers
Posted on 16 Jan 2003
A study has found that mutations in the connexin 43 gene underlie the hereditary syndrome oculodentodigital dysplasia, which is characterized by defects in many of the body's structures and systems, including the eyes, face, teeth, fingers and toes. More...
The study was published January 2, 2003, in the online edition of the American Journal of Human Genetics.

"It is pretty amazing that it has taken so long to link a connexin gene to a disorder that affects so many of the body's systems,” said senior author Dr. Ethylin Jabs, director of the Center for Craniofacial Development and Disorders at Johns Hopkins School of Medicine (Baltimore, MD, USA). "Connexin 43 and related genes are present in many tissues during development, but until now problems with connexins had only been tied to simpler manifestations.”

Connexin 43 was a good candidate for involvement in this developmental disorder, as it was known to play a role in establishing molecular connections between cells. Also, connexin 43 is activated in fetal development in a pattern that reflects the problems seen in oculodentodigital dysplasia.

The investigators determined the sequence of connexin 43 in affected and unaffected members of 17 families in the United States, the Netherlands, Norway, and Turkey and in 100 unrelated people. Only individuals with the disorder had mutations in connexin 43. A different mutation was found in each of the 17 families, but all changes prevented connexin 43 from successfully coding for its protein product.

The authors suggested that their findings should help improve understanding of how connexins contribute to the crucial signaling processes that underlie normal development and may one day lead to a genetic test for families with a history of the disorder.




Related Links:
Johns Hopkins

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.